With medical therapy and preventive aortic surgery, life expectancy in Marfan\'s syndrome approaches that of the general population. [@JR180043-1] Unique issues have arisen in caring for this population including counseling women with Marfan\'s syndrome on the risk of cardiovascular morbidity related to pregnancy. Current literature focuses on the cardiovascular risks of pregnancy prior to aortic surgery. Women with Marfan\'s syndrome and aortic diameter \< 40 mm are considered to have a relatively low risk (≤ 1%) of acute aortic dissection during pregnancy. [@JR180043-2] [@JR180043-3] [@JR180043-4] [@JR180043-5] However, aortic dissection risk is estimated as high as 10% in women with aortic root dilation \> 40 mm, rapid dilatation, or previous dissection. [@JR180043-2] [@JR180043-4] Women with Marfan\'s syndrome and aortic dilatation (especially \> 45 mm) may be counseled to undergo aortic root repair prior to pregnancy to reduce the risk of aortic dissection, [@JR180043-5] [@JR180043-6] although this has not been proven to be entirely protective. [@JR180043-4] [@JR180043-7] [@JR180043-8] [@JR180043-9] [@JR180043-10]

Little is known about the risk of acute aortic dissection related to pregnancy in women with Marfan\'s syndrome following aortic root replacement. Case reports have documented variable outcomes including successful and uncomplicated pregnancies [@JR180043-11] [@JR180043-12] [@JR180043-13] [@JR180043-14] [@JR180043-15] [@JR180043-16] [@JR180043-17] as well as acute aortic dissection. [@JR180043-4] [@JR180043-7] [@JR180043-8] [@JR180043-9] [@JR180043-10] Specific risk factors, coupled with hemodynamic changes and hormonal alternations, which occur during pregnancy and early postpartum may culminate in an acute aortic dissection in susceptible women. Given the paucity of data, it remains difficult to confidently counsel women with Marfan\'s syndrome with prior aortic root replacement on the risk of acute aortic dissection with pregnancy.

To further study this question, we queried a population of women with Marfan\'s syndrome with prior aortic root replacement on specific details of each pregnancy following their aortic surgery. We hypothesized that the risk of an aortic dissection related to pregnancy among women with Marfan\'s syndrome and prior aortic root replacement is low but not zero. We sought to examine potential risk factors for aortic complications related to pregnancy, such as prior aortic dissection, hypertension, lack of *β* -blocker use, number of pregnancies, and breastfeeding. We also sought to understand whether there was a significant variation in counseling provided to these women regarding their risk of pregnancy following aortic root replacement.

Methods
=======

A 32-question survey (see [Supplementary File 1](#SM180043-1){ref-type="supplementary-material"} ; available only in the online version) regarding the diagnosis of Marfan\'s syndrome, type of aortic root replacement, history of prior aortic dissection, cardiac and obstetric outcomes of pregnancies, details regarding aortic dissections occurring during pregnancy, and the postpartum period (including timing of dissection \[1st, 2nd or 3rd trimester, during labor and delivery, up to 2 weeks postpartum, 2--4 weeks postpartum, or greater than 4 weeks but less than 12 months postpartum\]), mode of delivery, method of anesthesia, presence of breastfeeding, use of *β* -blockers, presence of hypertension, eclampsia or preeclampsia, smoking, and use of anticoagulants was developed by the investigators and distributed through the Marfan Foundation Website research link and social media Website, [www.marfan.org](www.marfan.org) . The survey was tailored to ask the same set of questions for each pregnancy by using branching logic. The survey was distributed on the Marfan Foundation Website and social media site from October 2014 through March 2015. Women with Marfan\'s syndrome were excluded if they were under the age of 18 years or did not have a pregnancy following aortic root replacement. Washington University in St. Louis School of Medicine (WU) and the Johns Hopkins Hospital (JHH) Marfan\'s Syndrome Clinics identified additional women with Marfan\'s syndrome who had pregnancy following aortic root replacement. Pregnancies that resulted in miscarriage or therapeutic abortion were excluded from the final analysis. The institutional review boards at WU, the JHH, and the Marfan Foundation approved the survey.

A literature review was also conducted to identify additional cases of women with Marfan\'s syndrome with pregnancy after aortic root replacement. We performed an electronic search using PubMed with the following key terms: aortic root replacement, pregnancy, and Marfan\'s syndrome. Papers were excluded if it did not include women with Marfan\'s syndrome with pregnancy after aortic root replacement.

The institutional review boards at WU (IRB 201407102, approved August 2014), the JHH (NA_00037120, approved September 2010, updated November 2017), and the Marfan Foundation approved the survey.

Results
=======

We identified a total of 14 women with Marfan\'s syndrome who had 26 pregnancies after aortic root replacement consisting of 20 live births and 6 miscarriages. Seven women with 13 pregnancies were identified through the Marfan Foundation Website. Four women with eight pregnancies were identified from the WU Marfan\'s Syndrome Clinic. Three women with five pregnancies were identified at the JHH Marfan\'s Syndrome Clinic ( [Table 1](#TB180043-1){ref-type="table"} and [Table 2](#TB180043-2){ref-type="table"} ).

###### Pregnancy outcomes in women with Marfan\'s syndrome following aortic root replacement from survey and Marfan\'s clinics [a](#FN180043-2){ref-type="table-fn"}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient (pregnancy number following ARR)   Marfan\'s criteria                                                           Indication for ARR   Age at ARR (y)   Fetal outcome                                   Delivery type       Anesthesia           AD related to pregnancy                                                            BB   Chronic HTN   Hypertensive disorder of pregnancy [b](#FN180043-3){ref-type="table-fn"}   Smoking   Breast feeding ≥ 2 wk
  ------------------------------------------ ---------------------------------------------------------------------------- -------------------- ---------------- ----------------------------------------------- ------------------- -------------------- ---------------------------------------------------------------------------------- ---- ------------- -------------------------------------------------------------------------- --------- -----------------------
  1 (1)                                      Scoliosis, thumb sign, MVP, pes planus, lens dislocation, pectus carinatum   AA                   28               Term                                            Cesarean            Epidural             No                                                                                 \+   \+            −                                                                          −         \+

  1 (2)                                      Therapeutic abortion                                                         SVD                  None             No                                              \+                  \+                   −                                                                                  −    NA                                                                                                 

  1 (3)                                      Term                                                                         Cesarean             Epidural         No                                              \+                  \+                   −                                                                                  −    \+                                                                                                 

  2 (1)                                      Scoliosis, thumb sign, pectus excavatum                                      AA                   31               Term                                            SVD                 Epidural             No                                                                                 \+   \+            −                                                                          −         −

  3 (1)                                      *FBN1* mutation, lens dislocation, pneumothorax, thumb sign, FH of AD        AA                   31               Miscarriage                                     SVD                 General              No                                                                                 \+   −             −                                                                          −         NA

  3 (2)                                      Miscarriage                                                                  SVD                  General          No                                              \+                  −                    −                                                                                  −    NA                                                                                                 

  3 (3)                                      Term                                                                         SVD                  Epidural         No                                              \+                  −                    −                                                                                  −    \+                                                                                                 

  4 (1)                                      *FBN1* mutation, MVP, thumb sign, pectus excavatum                           AA                   24               Term                                            SVD                 Epidural             No                                                                                 −    −             −                                                                          −         \+

  4 (2)                                      Term                                                                         SVD                  Epidural         No                                              −                   −                    −                                                                                  −    \+                                                                                                 

  5 (1)                                      *FBN1* mutation, MVP, pectus excavatum, thumb sign, FH of AD                 AA                   32               Miscarriage                                     SVD                 None                 No                                                                                 \+   −             −                                                                          −         NA

  5 (2)                                      Preterm                                                                      Cesarean             General          No                                              \+                  −                    −                                                                                  −    \+                                                                                                 

  6 (1)                                      Pectus carinatum, pes planus                                                 AA                   27               Preterm                                         Cesarean            Epidural             No                                                                                 \+   −             −                                                                          NA        \+

  7 (1)                                      *FBN1* mutation, scoliosis, pectus carinatum                                 AA                   22               Term                                            Cesarean            Epidural             No                                                                                 \+   −             −                                                                          NA        −

  8 (1)                                      *FBN1* mutation, FH of Marfan\'s syndrome                                    AA                   22               Miscarriage                                     SVD                 General              No                                                                                 \+   −             −                                                                          −         NA

  8 (2)                                      Term                                                                         Cesarean             Epidural         No                                              \+                  −                    −                                                                                  −    −                                                                                                  

  8 (3)                                                                                                                                        Term             Cesarean                                        Epidural            No                   \+                                                                                 −    −             −                                                                          −         

  9 (1)                                      *FBN1* mutation, AA                                                          AA                   22               Preterm                                         SVD                 Epidural             No                                                                                 \+   \+            −                                                                          \+        +, 6 mo

  9 (2)                                      Preterm                                                                      Forceps assisted     Epidural         No, descending TAA 3 y after 2 ^nd^ pregnancy   \+                  \+                   −                                                                                  \+   +, 3 mo                                                                                            

  9 (3)                                      Preterm                                                                      Forceps assisted     Epidural         No                                              \+                  \+                   −                                                                                  \+   +, 3 mo                                                                                            

  10 (1)                                     *FBN1* mutation, dural ectasia, AA                                           AA                   26               Term                                            Cesarean            Spinal               No                                                                                 \+   −             −                                                                          −         +, \> 12 mo

  11 (1)                                     Ghent systemic score 9, AA                                                   AD                   29               Term                                            Forceps assisted    Epidural             No, [c](#FN180043-4){ref-type="table-fn"} Fatal type B dissection 1-y postpartum   \+   −             +, Preeclampsia                                                            −         +, 12 mo

  12 (1)                                     *FBN1* mutation, AA, FH of AD                                                AA                   24               Term                                            Cesarean            Epidural             No                                                                                 \+   −             −                                                                          −         \+

  13 (1)\                                    AA, scoliosis, FH of Marfan\'s syndrome                                      AA                   34               Miscarriage                                     Vacuum aspiration   Paracervical block   No                                                                                 \+   −             −                                                                          −         NA
  13 (2)                                                                                                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                Term                                            SVD                 Epidural             No                                                                                 \+   −             −                                                                          −         \+

  14 (1)\                                    AA, *FBN1* mutation, FH of Marfan\'s, high systemic score                    AD                   31               Term                                            SVD                 Epidural             No                                                                                 \+   −             −                                                                          −         −
  14 (2)                                                                                                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                Term                                            SVD                 Epidural             No                                                                                 \+   −             −                                                                          −         −
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: AA, Aortic Aneurysm; AD, aortic dissection; ARR, aortic root replacement;; BB, *β* -blocker; FH, family history; HTN, hypertension; MVP, mitral valve prolapse; NA, missing data or not applicable; SVD, spontaneous vaginal delivery; TAA, thoracic aortic aneurysm; +, present; −, absent

Washington University in St. Louis School of Medicine and Johns Hopkins University.

Hypertensive disorder of pregnancy: gestational hypertension, pre-eclampsia, eclampsia.

Smoking data was available for 18 live births.

###### Characteristics of women with Marfan\'s syndrome in online survey and WU/JHH Marfan\'s clinics

  ----------------------------------------------------------------------------------------------------------
   Variable                                                                   * n*  = 14 Marfan\'s women,\
                                                                               20 live birth pregnancies
  --------------------------------------------------------------------------- ------------------------------
   Age at aortic root replacement (y)                                          27.4 ± 4.1

   History of prior aortic dissection                                          2 (14.3%)

   Pregnancies following aortic root replacement                               1.4 ± 0.6

   Chronic hypertension                                                        3 (21.4%)

  * β* -blocker use per pregnancy                                              18 (90%)

   Smoking per pregnancy ^c^                                                   3 (16.7%)

   Antithrombotic therapy per pregnancy                                        6 (30%)

                                                                               Aspirin (1)

                                                                               Heparin (2)

                                                                               Warfarin (1)\
                                                                               Lovenox (2)

   Hypertensive disorder of pregnancy [b](#FN180043-7){ref-type="table-fn"}    1 (5%)

   Anesthesia use during delivery                                              Epidural 18 (90%)\
                                                                               General 1 (5%)\
                                                                               Spinal 1 (5%)

   Breastfeeding ≥ 2 wk per pregnancy                                          14 (70%)
  ----------------------------------------------------------------------------------------------------------

Abbreviations: JHH, John Hopkins Hospital; WU, Washington University in St. Louis School of Medicine.

Smoking data was available for 18 live births.

Hypertensive disorder of pregnancy includes gestational hypertension, preeclampsia, and eclampsia.

Twelve women (85.7%) had prior elective aortic root replacement for aneurysm disease. Two women (14.3%) underwent aortic root replacement due to a type A aortic dissection. The mean age at the time of aortic root replacement was 27.4 ± 4.1 years. Three (21.4%) women reported a history of chronic hypertension prior to pregnancy. One woman without preexisting hypertension developed preeclampsia during pregnancy. *β* blockers were prescribed in 18 of the 20 live birth pregnancies (90%). Smoking occurred during 3 (15%) of 20 live birth pregnancies. Antithrombotic (i.e., aspirin, warfarin, enoxaparin) therapy was used in six live birth pregnancies (30%). Indication for use of antithrombotic therapy was only known in three pregnancies (patients 9 and 14 who had a deep venous thrombosis and mechanical aortic valve replacement, respectively; [Table 1](#TB180043-1){ref-type="table"} ).

Of the 20 live birth pregnancies, 9 deliveries were by cesarean section (45%), 8 (40%) were spontaneous vaginal deliveries, and 3 (15%) were forcep-assisted vaginal deliveries. Five pregnancies (25%) were preterm. Eighteen deliveries (90%) had epidural anesthesia. Breastfeeding for at least 2 weeks occurred in 14 (70%) live birth pregnancies. Two women (patients 10 and 11) breastfed their infants longer than 12 months.

There were no aortic dissections related to pregnancy or in the immediate weeks postpartum among the women in our series. One woman suffered a fatal type B (descending) aortic dissection 1 year after delivery which was not deemed related to pregnancy because it occurred outside prespecified postpartum period of 1 month (patient 11; [Table 1](#TB180043-1){ref-type="table"} ). Another woman developed a descending thoracic aortic aneurysm requiring open surgical repair 3 years after her second pregnancy (patient 9, [Table 1](#TB180043-1){ref-type="table"} ). Following descending aortic repair, this woman went on to have a successful and uncomplicated third pregnancy and delivery.

All women except one in our series reported receiving some counseling on the risk of aortic dissection with pregnancy following aortic root replacement. Most women were not quoted a specific numerical risk of aortic dissection. Two women reported their physician recommend against pregnancy following aortic root replacement.

Literature Review
=================

A comprehensive literature review was performed identifying reports of pregnancy outcomes in women with Marfan\'s syndrome after prior aortic root replacement. We compiled data on 24 women with Marfan\'s syndrome who had 24 pregnancies after prior aortic root replacement **(** [Table 3](#TB180043-3){ref-type="table"} ). [@JR180043-4] [@JR180043-7] [@JR180043-8] [@JR180043-9] [@JR180043-10] [@JR180043-11] [@JR180043-12] [@JR180043-13] [@JR180043-14] [@JR180043-15] [@JR180043-16] [@JR180043-17] Of these 24 pregnancies, there were 23 live births and one fetal demise due to aortic dissection in the second trimester. Three of the 24 women had undergone aortic root replacement for acute type A (ascending) aortic dissection, and 13 patients had elective aortic surgery for aneurysm. Indication for aortic root replacement was not known in eight women. Of the 22 women for whom further data are available, 8 (36.4%) patients underwent a composite aortic valve and root replacement, 13 underwent valve-sparing root replacement (59.1%), and 1 underwent aortic homograft root replacement. The use of *β* -blocker therapy was known in 11 women. Of those 11 women, 8 (72.7%) used a *β* -blocker during pregnancy. Methods of delivery were reported in 16 pregnancies and included cesarean delivery in 13 women, spontaneous vaginal delivery in 2, and forceps assisted in 1.

###### Literature review of pregnancy outcomes in women with Marfan\'s syndrome following aortic root repair

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                 *n*   Indication for ARR                        ARR type          *β* -blocker   Method of delivery   Anesthesia           Aortic complications                                                                                        Counseling
  ------------------------- ----- ----------------------------------------- ----------------- -------------- -------------------- -------------------- ----------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------
  Rossiter [@JR180043-4]    1     Type A AD extending into thoracic aorta   CVG               Yes            Unknown              Unknown              Extension of type B AD 1 wk postpartum                                                                      Advised against pregnancy; Patient used illicit intravenous drugs, including cocaine before and during pregnancy

  Donnelly [@JR180043-11]   3     AA                                        2 VSRR 1 CVG      Unknown        Unknown              Unknown              No dissection but worsened aortic regurgitation in both women with VSRR                                     Unknown

  McDermott [@JR180043-7]   1     AA                                        VSRR              Yes            NA                   NA                   Fatal type B AD in 2nd trimester; fetal demise, SBP on presentation \> 200 mm Hg                            Preconception counseling recommended against pregnancy before aortic repair and reevaluation after surgery

  Tutarel [@JR180043-12]    1     Type A AD extending into iliac arteries   CVG               Yes            Cesarean             Unknown              No further extension of chronic dissection which was confirmed by MRI in 3 ^rd^ trimester of pregnancy      Unknown

  Williams [@JR180043-13]   1     AA                                        Homo-graft root   Yes            Forceps-assisted     Unknown              None                                                                                                        Quoted risk of aortic root dissection to be \< 10%

  Allyn [@JR180043-14]      2     Unknown                                   Unknown           Unknown        Cesarean             General anesthesia   None                                                                                                        Advised against pregnancy if history of AD or mechanical aortic valve

  Omnes [@JR180043-15]      3     Unknown                                   3 VSRR            Unknown        Cesarean             General anesthesia   None                                                                                                        Advised against pregnancy if history of AD or mechanical aortic valve

  Curry [@JR180043-16]      3     Unknown                                   1 CVG 2 VSRR      Unknown        Unknown              Unknown              None                                                                                                        Unknown

  Meijboom [@JR180043-8]    2     1-Type A AD\                              2 CVG             Unknown        Cesarean             Unknown              Patient with prior Type A AD, developed a Type B AD at 27 wk, underwent surgical repair at 34 wk delivery   28% had not conceived based on advice from cardiologist
                                  2-AA                                                                                                                                                                                                                             

  Chavanon [@JR180043-9]    1     AA                                        VSRR              Yes            Cesarean             General              Type B AD 2 d after delivery and worsening aortic regurgitation                                             Unknown

  Volach [@JR180043-17]     1     AA                                        CVG               Yes            Cesarean             Epidural             None                                                                                                        Unknown

  Sayama [@JR180043-10]     5     1-AA\                                     1-VSRR\           1-No\          1-Cesarean\          1-Unknown\           1-None\                                                                                                     Unknown
                                  2-AA\                                     2-CVG\            2-No\          2-Vaginal\           2-Epidural\          2-None\                                                                                                     
                                  3-AA\                                     3-VSRR\           3-Yes\         3-Cesarean\          3-Unknown\           3-Type B AD at 36 wk\                                                                                       
                                  4-AA\                                     4-VSRR\           4-Yes\         4-Cesarean\          4-Unknown\           4-Type B AD 5 d postpartum\                                                                                 
                                  5-AA                                      5-VSRR            5-No           5-Vaginal            5-Epidural           5-Type B AD 11 d postpartum                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: AA, aortic aneurysm; AD, aortic dissection; ARR, aortic root replacement; CVG, composite valve graft; MRI, magnetic resonance imaging; N, number of pregnancies ARR; SBP, systolic blood pressure; VSRR, valve sparing root replacement.

Acute aortic dissection related to pregnancy was reported in 7 of 24 women with Marfan\'s syndrome (29.2%) who had undergone prior aortic root replacement. [@JR180043-4] [@JR180043-7] [@JR180043-8] [@JR180043-9] [@JR180043-10] Chavanon et al reported a case of a woman who suffered an acute type B aortic dissection and worsening aortic regurgitation two days after delivery. [@JR180043-9] McDermott et al reported one woman who sustained an acute type B dissection and severe hypertension in the second trimester, resulting in patient death and intrauterine fetal demise. [@JR180043-7] Meijboom et al reported the case of a woman with a prior type A aortic dissection and composite aortic valve graft who suffered an acute type B aortic dissection at 27 weeks of gestation. [@JR180043-8] She was treated with initial medical therapy, undergoing a cesarean delivery at 34 weeks, and subsequently elective aortic repair after delivery. Rossiter et al reported a patient with a prior acute type A dissection with chronic dissection of the descending thoracic aorta who suffered an extension of the chronic descending dissection 1 week postpartum. [@JR180043-4] This patient used illicit drugs including cocaine during her pregnancy. Sayama reported five women with Marfan\'s syndrome who had pregnancy after aortic root replacement and strikingly, three of the five patients (60%) in this series suffered a type B aortic dissection related to pregnancy. [@JR180043-10]

Regarding counseling from the literature review, some authors recommended against pregnancy if patients were deemed to have risk factors for aortic dissection, specifically a prior aortic dissection. [@JR180043-4] [@JR180043-14] [@JR180043-15]

Discussion
==========

In our case series, there were no aortic dissections among 20 successful pregnancies in 14 women with Marfan\'s syndrome who had undergone aortic root replacement before pregnancy. Most of our patients did not have additional risk factors for a high-risk pregnancy (i.e., hypertension, smoking) which may have been protective against aortic dissection; all patients except one were prescribed and presumably compliant with *β* -blocker therapy. Patient 9 ( [Table 1](#TB180043-1){ref-type="table"} ) had a history of smoking and hypertension and developed a descending thoracic aneurysm after a second pregnancy. Whether hypertension, smoking, and multiparity were risk factors in her progressive aneurysm disease is unknown. The mode of delivery, the method of anesthesia, or breastfeeding was not related to aortic events.

Our report represents the largest series to date describing aortic outcomes related to pregnancy in women with Marfan\'s syndrome who had undergone prior aortic root replacement. Differing from high incidence from case reports in the literature, no women in our series suffered aortic dissection related to pregnancy.

There are several limitations to this study including the observational nature, small sample size, potential for sampling error, and recall bias. The patients surveyed and those from the Marfan syndrome clinics represent a survivor cohort, so the risk of aortic complications may be underestimated. We were unable to assess for compliance with medications or other complications of pregnancy following valve sparing aortic root replacement, such as aortic regurgitation. Additionally, complete medical records were not available for all patients obtained from our survey and clinics at WU and JHH. Thus, the information gathered is subject to recall bias. Furthermore, two women (patients 2 and 6) in our study did not provide all data to satisfy the revised Ghent criteria for Marfan\'s syndrome ( [Table 1](#TB180043-1){ref-type="table"} ). [@JR180043-18] Thus, it is possible these subjects did not have Marfan\'s syndrome but a related aortopathy syndrome. Despite these limitations, our series is the largest to date examining aortic outcomes related to pregnancy in women with Marfan\'s syndrome with prior aortic root replacement.

Our results contrast with prior published reports. The results of the literature review may result in overestimation of the risk of aortic dissection related to pregnancy after aortic root replacement due to a reporting or publication bias. Importantly, one report had a very high percentage of pregnancy-related aortic dissections (60%) which may create bias toward increased risk. [@JR180043-10] The indication for aortic surgery was not reported in all women from the literature review limiting our ability to be certain about risks of aortic dissection related to prior aortic events. As compiled from our case series, the risk of aortic dissection related to pregnancy after root replacement in women with Marfan\'s syndrome is likely lower than that reported in the literature.

While many experts have recommended that women with Marfan\'s syndrome and aortic dilatation undergo elective aortic root replacement before contemplating pregnancy, the risk of acute aortic dissection during subsequent pregnancy is poorly understood. [@JR180043-5] The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) registry reported pregnancy-related aortic dissection risk (5.4 per 100 patient years) for women with Marfan\'s syndrome but did not include any women with pregnancy following aortic root replacement. [@JR180043-19] Pregnancy in Marfan\'s syndrome is known to be a risk factor for aortic complications due to the underlying aortopathy and pregnancy-related molecular, hormonal, and hemodynamic changes. [@JR180043-3] [@JR180043-20] Most aortic dissections during pregnancy in these women occur in the third trimester and early postpartum period. [@JR180043-3] [@JR180043-11] [@JR180043-19] This may be related to pregnancy-related hemodynamic or hormonal changes which may persist for several weeks postpartum. [@JR180043-21] Alterations in elastic fibers and mucopolysaccharides have also been described during pregnancy. [@JR180043-22] Aortic root growth rate in Marfan\'s syndrome is reported to accelerate during pregnancy but following pregnancy, the aortic root growth reverts to a prepregnancy rate. [@JR180043-11] In patients with Marfan\'s syndrome who have undergone prior valve sparing root replacement, an increase in the degree aortic regurgitation during pregnancy and postpartum is reported. [@JR180043-9] [@JR180043-11]

Prior aortic root replacement may be a risk factor for distal aortic events in Marfan\'s syndrome [@JR180043-23] with late type B dissection being reported in approximately 9% of patients. [@JR180043-24] [@JR180043-25] Independent risk factors for dissection include prior root replacement, aortic dilatation, and decreased aortic distensibility while angiotensin receptor blockers were protective. [@JR180043-26] It is hypothesized that abnormal elastic properties related to the aortic root vascular prosthesis may result in higher pulsatile forces on the native aortic arch and proximal descending aorta which can affect distal aortic events. [@JR180043-24] [@JR180043-26]

Beta adrenergic blockers and angiotensin II receptor blockers are beneficial in managing aortic disease in Marfan\'s syndrome and *β* -blockers are recommended for women with Marfan\'s syndrome during pregnancy. [@JR180043-5] [@JR180043-6] [@JR180043-27] Whether *β* -blockers have a protective benefit during pregnancy has not been studied. Angiotensin II receptor blockers are contraindicated during pregnancy due to their teratogenicity. Following aortic root replacement surgery, long-term *β* -blocker therapy is recommended in Marfan\'s syndrome to lessen aortic wall stress. [@JR180043-5]

Loeys--Dietz syndrome, sometimes initially diagnosed as Marfan\'s syndrome, has a more aggressive vascular phenotype than Marfan\'s syndrome and aortic dissection is reported related to pregnancy in this condition. [@JR180043-23] [@JR180043-28] Pregnancy following root replacement in Loeys--Dietz syndrome is reported and associated with a very high rate of distal aortic dissection. [@JR180043-29]

Conclusion
==========

A multidisciplinary approach including cardiology, medical genetics, maternal fetal medicine, anesthesia (and cardiac surgery as appropriate) is recommended in the care of women with Marfan\'s syndrome contemplating pregnancy. Management should include *β* -blockers during pregnancy, control of hypertension and tobacco cessation. There are insufficient data available to inform counseling on breastfeeding. Imaging of the aorta should be performed prior to pregnancy, during pregnancy, and in the postpartum period. Women who have undergone valve-sparing root replacement should have echocardiography to evaluate for aortic regurgitation. Women and their physicians should be vigilant for signs and symptoms of acute aortic dissection during pregnancy and postpartum.

Women with Marfan\'s syndrome who have undergone prior aortic root replacement and desire pregnancy should be counseled that they remain at risk for distal aortic dissection related to pregnancy. The exact risk of pregnancy following elective root replacement is difficult to calculate but it is not zero. The risk is likely higher when aortic surgery was performed for an aortic dissection or if residual dissection is present than when performed for asymptomatic aneurysm disease. Discussion of the potential for aortic complications should take place prior to pregnancy for women with Marfan\'s syndrome who have undergone prior aortic surgery.
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